Zydus Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	532321	NSE Symbol:	ZYDUSLIFE	P/E :	34.04
ISIN Demat:	INE010B01027	Div & Yield %:	0.08	EPS :	36.54
Book Value:	237.30	Market Cap (Rs. Cr.):	124,089.48	Face Value :	1

Date	Headline
19-Oct-26	Zydus Lifesciences to convene a board meeting November 4 to review financial results
06-Oct-26	Zydus Lifesciences cancelled dematerialized equity shares following verification by MUFG Intime Indi
01-Oct-26	Zydus Lifesciences extends investment completion date in Zydus Sunshine Lifesciences to December 202
26-Sep-26	Zydus Lifesciences will halt trading for insiders ahead of September 2026 results
11-Aug-26	Zyudus Lifesciences shareholders re-elected Dr. Patel as Managing Director for five years
04-Aug-26	Zydus Lifesciences secures USFDA approval for Indocyanine Green, gaining 180-day exclusivity
01-Aug-26	Zydus Lifesciences gets USFDA EIR for Ahmedabad injectable facility with VAI classification
23-Jul-26	Zydus receives permission for Phase III trial of Desidustat
20-Jul-26	Zydus Lifesciences to conduct board meeting
03-Jul-26	Zydus partners with Guardant Health and Apollo Hospitals to introduce Shield™ MCD in India

Company Snapshot